IFF Price Prediction Next Week
Based on the provided data, here is the analysis for IFF's stock price prediction for next week:
Technical Analysis:
- RSI indicators show oversold conditions (RSI-14: 32.01)
- MACD is bearish with negative values (-0.99) and bearish histogram (-0.59)
- Stochastic indicators are deeply oversold (14.09)
- Price is trading below all major moving averages (5,10,20,60,200,250 SMAs)
Recent Price Action:
- Current price: $79.90
- Recent downward trend with significant selling pressure
- Price has fallen from $81.10 to $79.45 over the past week
- Volume increased during the decline, indicating strong selling momentum
Support/Resistance Levels:
- Key support levels: $78.27 (Fibonacci S2)
- Key resistance levels: $83.24 (Fibonacci pivot), $86.32 (Fibonacci R1)
News Impact:
- CFRA recently double-downgraded IFF to sell from buy, indicating negative analyst sentiment
- Stock dropped more than 2% following the downgrade
- Broader market weakness and consumer demand concerns are adding pressure
Price Prediction for Next Week: Based on technical indicators and recent price action:
- Most likely scenario (60% probability): Further decline to test $78.27 support
- Target price range: $77.50-$78.50
- If support breaks, next target would be $75.19 (Fibonacci S3)
Recommendation: SELL
- Current technical setup suggests continued downward pressure
- Multiple indicators showing bearish signals
- Negative analyst sentiment and market conditions support bearish outlook
- Suggested entry for short positions: Current market price ($79.90)
- Stop loss: Above $83.24 (Fibonacci pivot)
IFF Similar Chart Price Prediction
The price of IFF is predicted to go up 7.68%, based on the high correlation periods with MTRN. The similarity of these two price pattern on the periods is 94.83%.
IFF
MTRN
Up: 7.68%Similarity: 94.83%
IFF Revenue Forecast
IFF EPS Forecast
IFF FAQs
What is bull’s view on IFF?
What is bear's view on IFF?
What is IFF revenue forecast for next quarter？
What is IFF eps forecast for next quarter？
IFF VS S&P500
As the largest specialty ingredients producer globally, IFF holds an enviable portfolio of market-leading products spanning multiple industries.
The company is well positioned to capitalize on multiple growing end markets, including natural flavors, enzymes, cultures, and pharmaceutical excipients.
IFF's high R&D spending (around 6% of sales) acts as a barrier to entry, underpins innovation, and promotes future growth.
IFF Analyst's Forecast
Kristen Owen
Oppenheimer
Buy
2025-02-20
Price Target
$114 → $104
Upside
+30.18%
Oppenheimer lowered the firm's price target on IFF to $104 from $114 and keeps an Outperform rating on the shares. The firm views IFF's 5.2% sell-off Wednesday as overdone, with the moving pieces on the guidance requiring a bit of digestion. While the Pharma sale was widely communicated, the F/X headwinds to EBITDA were a bit higher than expected, contributing to the shortfall vs. Street. That said, Oppenheimer believes the underlying fundamentals of the business under the new leadership team are encouraging and focused on areas that it thinks position IFF to not only maintain, but potentially expand its market share over time.
Michael Sison
Wells Fargo
Buy
2025-02-20
Price Target
$115 → $105
Upside
+31.43%
Lauren Lieberman
Barclays
Hold
2025-01-17
Price Target
$90 → $88
Upside
+3.66%
